Barclays PLC
- SEC CIK
- 0000312069
- Latest filing
- Aug 14, 2026
ADCT holding history
ADC Therapeutics SA in every 13F filed by Barclays PLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ADCT overviewAll 13F holders of ADCTFull Q2 2026 holdings
- Shares (Q2 2026)
- 94,264
- Value
- $100.9K
- % of portfolio
- <0.1%
- Quarters held
- 11
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 94,264 | $100.9K | <0.1% | +47,929+103.4% | Added | Holders |
| Q1 2026 | 46,335 | $173.8K | <0.1% | −115,051−71.3% | Reduced | Holders |
| Q4 2025 | 161,386 | $569.7K | <0.1% | +30,926+23.7% | Added | Holders |
| Q3 2025 | 130,460 | $521.8K | <0.1% | −14,947−10.3% | Reduced | Holders |
| Q2 2025 | 145,407 | $389.7K | <0.1% | +44,373+43.9% | Added | Holders |
| Q1 2025 | 101,034 | $142.5K | <0.1% | −40,461−28.6% | Reduced | Holders |
| Q4 2024 | 141,495 | $281.6K | <0.1% | +13,756+10.8% | Added | Holders |
| Q3 2024 | 127,739 | $402.4K | <0.1% | +93,890+277.4% | Added | Holders |
| Q2 2024 | 33,849 | $107.0K | <0.1% | +33,849 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −314,925−100.0% | Sold out | Holders |
| Q2 2023 | 314,925 | $677.1K | <0.1% | −19,347−5.8% | Reduced | Holders |
| Q1 2023 | 334,272 | $651.8K | <0.1% | +334,272 | New | Holders |